|Articles|October 14, 2020
- Pharmaceutical Executive-10-01-2020
- Volume 40
- Issue 10
Pharmaceutical Executive, October 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive October 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
The SPAC Makes a Comeback!over 5 years ago
Leadership and Industry Imageover 5 years ago
The Interplay Between COVID-19 Pandemic and NCD Epidemicover 5 years ago
FDA Struggles to Retain Credibilityover 5 years ago
Critical Connection: Patient Services and Product Launchover 5 years ago
Mastering the Transition From Academia to Industryover 5 years ago
Smoothing Access Pathover 5 years ago
The COVID Boost to AI in Global Healthover 5 years ago
Speed and SensitivityNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
3
ACIP Member Claims FDA Commissioner is Halting Decision to Remove Covid Vaccines from the Market: Report
4
From OR to Office: How Workflow Change and AI Are Reshaping MedTech Adoption
5

